pyrrolidine-2,4-dicarboxylic acid has been researched along with Fragile X Syndrome in 1 studies
pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z | 1 |
| Hulsizer, S | 1 |
| Cui, Y | 1 |
| Pretto, DL | 1 |
| Kim, KH | 1 |
| Hagerman, PJ | 1 |
| Tassone, F | 1 |
| Pessah, IN | 1 |
1 other study available for pyrrolidine-2,4-dicarboxylic acid and Fragile X Syndrome
| Article | Year |
|---|---|
Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion.
Topics: Animals; Astrocytes; Ataxia; Biological Transport; Calcium Signaling; Cells, Cultured; Cerebral Cort | 2013 |